CTLA 4 News and Research

RSS
Patients with soft-tissue cancer show rapid and complete response to novel combination of immunotherapy

Patients with soft-tissue cancer show rapid and complete response to novel combination of immunotherapy

Neoadjuvant trial of combination immunotherapy has favorable outcomes in bladder cancer patients

Neoadjuvant trial of combination immunotherapy has favorable outcomes in bladder cancer patients

New biomarker may help identify patients at risk for graft-versus-host disease after stem cell transplants

New biomarker may help identify patients at risk for graft-versus-host disease after stem cell transplants

Ludwig study uncovers a nutritional approach to improve cancer immunotherapy

Ludwig study uncovers a nutritional approach to improve cancer immunotherapy

Antibody improves progression-free survival in patients with advanced prostate cancer

Antibody improves progression-free survival in patients with advanced prostate cancer

Engineered, high-affinity ACE2 receptors neutralize SARS-CoV-2

Engineered, high-affinity ACE2 receptors neutralize SARS-CoV-2

Study sheds light on how interferon-gamma drives response to immunotherapy in melanoma

Study sheds light on how interferon-gamma drives response to immunotherapy in melanoma

Harbour BioMed and Viva Biotech announce strategic collaboration to promote incubation of biotech startups

Harbour BioMed and Viva Biotech announce strategic collaboration to promote incubation of biotech startups

Dysfunctional T cells present at high levels in severe COVID-19

Dysfunctional T cells present at high levels in severe COVID-19

SWOG scientists to deliver online presentations at ASCO20 Virtual Scientific Program

SWOG scientists to deliver online presentations at ASCO20 Virtual Scientific Program

Bio-Rad Introduces Anti-Ipilimumab Antibodies

Bio-Rad Introduces Anti-Ipilimumab Antibodies

Immunotherapy may benefit mCRPC patients with specific markers of immune activation

Immunotherapy may benefit mCRPC patients with specific markers of immune activation

Immunotherapy combination can shrink viral reservoir in HIV model

Immunotherapy combination can shrink viral reservoir in HIV model

Levels of sBTLA proteins may be a marker of overall survival in patients with HCC

Levels of sBTLA proteins may be a marker of overall survival in patients with HCC

Pre-operative immunotherapy can elicit an immune response that shrinks oral cancers

Pre-operative immunotherapy can elicit an immune response that shrinks oral cancers

Immunotherapy drug combination effective for patients with fast-growing neuroendocrine tumors

Immunotherapy drug combination effective for patients with fast-growing neuroendocrine tumors

Using newly discovered immune cell type to fight pancreatic cancer

Using newly discovered immune cell type to fight pancreatic cancer

Researchers engineer probiotics to safely deliver immunotherapies to tumors

Researchers engineer probiotics to safely deliver immunotherapies to tumors

Immunosupressant combination therapy for glioblastoma shows promise

Immunosupressant combination therapy for glioblastoma shows promise

Transitional T cells could help improve cancer immunotherapy

Transitional T cells could help improve cancer immunotherapy